Literature DB >> 3119653

Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis.

H Reichel1, H P Koeffler, R Barbers, A W Norman.   

Abstract

Regulation of the production of the biologically active vitamin D3 sterol 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] by cultured pulmonary alveolar macrophages (PAM) obtained from 6 patients with pulmonary sarcoidosis and from 9 normal subjects was studied. The sarcoid cells, all collected from patients with normal calcium metabolism, synthesized 1,25-(OH)2-[3H]D3 from the substrate 25-hydroxyvitamin [3H]D3 (25OH-[3H]D3), whereas in vitro incubation with recombinant human interferon-gamma (IFN gamma) or lipopolysaccharide (LPS) was required for induction of synthesis of the hormone by normal PAM. Exogenous 1,25-(OH)2D3 (10-100 nmol/L) decreased endogenous hormone production by normal PAM by approximately 45%. The relative inhibitory effect of 1,25-(OH)2D3 was less pronounced in sarcoid PAM, in which 10-100 nmol/L 1,25-(OH)2D3 inhibited 250HD3-1-hydroxylase by approximately 25%. An accompanying induction of the 250HD3-24-hydroxylase, which is typical for renal cells, was found at low levels in only 3 of 10 experiments; in this regard, no differences between sarcoid and normal PAM were apparent. PTH or forskolin did not influence 250HD3 metabolism by PAM. 1,25-(OH)2D3 production by sarcoid PAM was enhanced by lipopolysaccharide and IFN gamma. Likewise, recombinant human interleukin-2 stimulated 1,25-(OH)2D3 production by sarcoid PAM, suggesting a possible role for both IFN gamma and interleukin-2 in the induction of 1,25-(OH)2D3 synthesis by sarcoid PAM in vivo. Recombinant human IFN alpha, IFN beta, and granulocyte-macrophage colony-stimulating factor had little effect. Dexamethasone and chloroquine, which have in vivo antihypercalcemic activity in sarcoidosis, both inhibited 1,25-(OH)2D3 synthesis by sarcoid PAM; chloroquine simultaneously stimulated the 24-hydroxylase. Our studies suggest that the 250HD3-metabolizing system in PAM is in some respects different from renal metabolism of 250HD3.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119653     DOI: 10.1210/jcem-65-6-1201

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

Review 1.  Structure function studies: identification of vitamin D analogs for the ligand-binding domains of important proteins in the vitamin D-endocrine system.

Authors:  A W Norman; F R Silva
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis.

Authors:  Giovanna Capolongo; Li Hao Richie Xu; Mariasofia Accardo; Alessandro Sanduzzi; Anna Agnese Stanziola; Annamaria Colao; Carlo Agostini; Miriam Zacchia; Giovambattista Capasso; Beverley Adams-Huet; Orson W Moe; Naim M Maalouf; Khashayar Sakhaee; Connie C W Hsia
Journal:  J Investig Med       Date:  2016-04-06       Impact factor: 2.895

Review 3.  Clinical impact of bone and calcium metabolism changes in sarcoidosis.

Authors:  G Rizzato
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

4.  [Disorders of calcium metabolism].

Authors:  C Kasperk; H Bartl
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

5.  Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription.

Authors:  Marcos Vidal; Chilakamarti V Ramana; Adriana S Dusso
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 6.  Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase.

Authors:  J S Adams; M Hewison
Journal:  Arch Biochem Biophys       Date:  2012-03-14       Impact factor: 4.013

Review 7.  Vitamin D effects on lung immunity and respiratory diseases.

Authors:  Sif Hansdottir; Martha M Monick
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

8.  Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice.

Authors:  M W Vaisberg; R Kaneno; M F Franco; N F Mendes
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

9.  Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense.

Authors:  Sif Hansdottir; Martha M Monick; Sara L Hinde; Nina Lovan; Dwight C Look; Gary W Hunninghake
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis.

Authors:  G Chandra; P Selvaraj; M S Jawahar; V V Banurekha; P R Narayanan
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.